Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01658917 · ClinicalTrials.gov registry record
Collecting Solid Tumor Tissue to Identify New Treatments
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 133
- Enrollment target
NCT01658917: Completed study, sponsored by National Cancer Institute (NCI).
NCT01658917 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 133 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01658917 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
Study Summary
Background: The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow tissue samples obtained during the protocol screening process to be used for future and ongoing research in the NCI Surgery Branch Eligibility: Patients must meet the minimum eligibility criteria for an NCI surgery Branch Treatment Protocol Design Patients will undergo testing and evaluations as required by the appropriate NCI Surgery Branch Treatment protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2012-07-24 |
| Est. Completion | 2017-10-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01658917
The ClinicalTrials.gov registry entry for NCT01658917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01658917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01658917 about?
NCT01658917 is a clinical study titled "Collecting Solid Tumor Tissue to Identify New Treatments". Background: The NCI Surgery Branch has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow tissue samples o...
What is the current status of trial NCT01658917?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2012-07-24. Estimated completion is 2017-10-23.
Who is sponsoring clinical trial NCT01658917?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.